Challenges and Opportunities for the Large-Scale Chemoenzymatic Glycoengineering of Therapeutic N-Glycosylated Monoclonal Antibodies

Overview of attention for article published in Frontiers in Catalysis, February 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 6 Mendeley

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 1,171 followers.

Continuing @FrontCatalysis' two year celebration 🎉 Today we celebrate our most viewed article published in February 2022 with over 7000 views. This review explores the challenges in large-scale chemoenzymatic glycoengineering 🙌 👀https://t.co/xyxGQstTSF 📚

04 Nov 2022

Reply Repost Favourite

New Research: Challenges and Opportunities for the Large-Scale Chemoenzymatic Glycoengineering of Therapeutic N-Glycosylated Monoclonal Antibodies https://t.co/BTDZMqL8f2 #Catalysis

03 Feb 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.